Insights From a Patient With Lung Cancer-Party Therapy Is Way Better Than Chemotherapy

JAMA Oncol. 2019 Dec 1;5(12):1685-1686. doi: 10.1001/jamaoncol.2019.2591.
No abstract available

MeSH terms

  • Disease Progression
  • ErbB Receptors / genetics
  • Female
  • Gefitinib / therapeutic use*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Mutation
  • Narration
  • Neoplasm Metastasis
  • Physician-Patient Relations
  • Quality of Life / psychology*

Substances

  • EGFR protein, human
  • ErbB Receptors
  • Gefitinib